| Johanna Albrecht, MD | |
|
200 Nw 7th Ave, Fort Lauderdale, FL 33311-9026 | |
| (954) 759-6600 | |
| (954) 759-6665 |
| Full Name | Johanna Albrecht |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 200 Nw 7th Ave, Fort Lauderdale, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104835305 | NPI | - | NPPES |
| ME0058024 | Other | FL | LICENSE NUMBER |
| 064812400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME0058024 (Florida) | Primary |
| Entity Name | North Broward Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801581129 PECOS PAC ID: 3577472422 Enrollment ID: O20040405001860 |
News Archive
New research suggests that saffron provides a significant chemopreventive effect against liver cancer in animal models. When saffron was administered to rats with diethylnitrosamine (DEN)-induced liver cancer an inhibition of cell proliferation and stimulation of apoptosis was observed. Full findings appear in the September issue of Hepatology, a journal published by Wiley Blackwell on behalf of the American Association for the Study of Liver Diseases.
Fifty-one percent of insured U.S. residents last year took one or more prescription drugs for chronic diseases, compared with 50% in the previous four years and 47% in 2001, according to a report released last Tuesday by Medco Health Solutions, the AP/Houston Chronicle reports.
A study by the UPV/EHU has assessed the effectiveness of various drugs, which are used to delay cognitive deterioration in patients with Alzheimer's, in improving cognitive impairment displayed by patients with schizophrenia.
According to the Journal, the number of young people caring for parents with debilitating conditions - such as Lou Gehrig's disease, multiple sclerosis, lupus, cancer and heart disease - is "large and expected to grow" as advances in medicine and technology allow people with such conditions to live longer.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Johanna Albrecht, MD 803 N Swinton Ave, Delray Beach, FL 33444-3961 Ph: () - | Johanna Albrecht, MD 200 Nw 7th Ave, Fort Lauderdale, FL 33311-9026 Ph: (954) 759-6600 |
News Archive
New research suggests that saffron provides a significant chemopreventive effect against liver cancer in animal models. When saffron was administered to rats with diethylnitrosamine (DEN)-induced liver cancer an inhibition of cell proliferation and stimulation of apoptosis was observed. Full findings appear in the September issue of Hepatology, a journal published by Wiley Blackwell on behalf of the American Association for the Study of Liver Diseases.
Fifty-one percent of insured U.S. residents last year took one or more prescription drugs for chronic diseases, compared with 50% in the previous four years and 47% in 2001, according to a report released last Tuesday by Medco Health Solutions, the AP/Houston Chronicle reports.
A study by the UPV/EHU has assessed the effectiveness of various drugs, which are used to delay cognitive deterioration in patients with Alzheimer's, in improving cognitive impairment displayed by patients with schizophrenia.
According to the Journal, the number of young people caring for parents with debilitating conditions - such as Lou Gehrig's disease, multiple sclerosis, lupus, cancer and heart disease - is "large and expected to grow" as advances in medicine and technology allow people with such conditions to live longer.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
› Verified 5 days ago
Dianne Mattox Parker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 S Andrews Ave, Newborn Nursery, Fort Lauderdale, FL 33316 Phone: 954-355-5810 | |
Dr. Paula Michele Thaqi, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 780 Sw 24th St, Fort Lauderdale, FL 33315 Phone: 954-467-4700 Fax: 954-467-4704 | |
Alochana Ragula, MBBS Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 S Andrews Ave, Fort Lauderdale, FL 33316 Phone: 954-459-2094 Fax: 954-320-2891 | |
Tonya Grissam, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6451 N Federal Hwy Ste 800, Fort Lauderdale, FL 33308 Phone: 800-586-5022 Fax: 954-229-9801 | |
Alexis Dietz, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 915 Middle River Dr Ste 209, Fort Lauderdale, FL 33304 Phone: 954-300-1736 | |
Dr. Natasha Mendez, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1625 Se 3rd Ave Ste 200, Fort Lauderdale, FL 33316 Phone: 954-832-0332 Fax: 954-832-0289 |